CN111944796B - D-mannose isomerase and application thereof - Google Patents
D-mannose isomerase and application thereof Download PDFInfo
- Publication number
- CN111944796B CN111944796B CN202010811740.9A CN202010811740A CN111944796B CN 111944796 B CN111944796 B CN 111944796B CN 202010811740 A CN202010811740 A CN 202010811740A CN 111944796 B CN111944796 B CN 111944796B
- Authority
- CN
- China
- Prior art keywords
- mannose
- fructose
- isomerase
- ala
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 101710104730 D-mannose isomerase Proteins 0.000 title claims abstract description 53
- 238000006243 chemical reaction Methods 0.000 claims abstract description 72
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims abstract description 58
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims abstract description 38
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 claims abstract description 36
- 238000000034 method Methods 0.000 claims abstract description 32
- 241000588724 Escherichia coli Species 0.000 claims abstract description 29
- 239000000758 substrate Substances 0.000 claims abstract description 29
- 238000006555 catalytic reaction Methods 0.000 claims abstract description 13
- 239000013612 plasmid Substances 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 5
- 230000009466 transformation Effects 0.000 claims description 5
- 239000003054 catalyst Substances 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 239000002773 nucleotide Substances 0.000 claims description 4
- 125000003729 nucleotide group Chemical group 0.000 claims description 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims 4
- 230000010307 cell transformation Effects 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 abstract description 30
- 108090000790 Enzymes Proteins 0.000 abstract description 30
- 230000000694 effects Effects 0.000 abstract description 24
- 229930091371 Fructose Natural products 0.000 abstract description 2
- 239000005715 Fructose Substances 0.000 abstract description 2
- 238000009776 industrial production Methods 0.000 abstract description 2
- 238000003259 recombinant expression Methods 0.000 abstract description 2
- 241000208189 Thermobifida halotolerans Species 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 37
- 239000000243 solution Substances 0.000 description 36
- 108090000623 proteins and genes Proteins 0.000 description 34
- 102000004169 proteins and genes Human genes 0.000 description 18
- 239000006228 supernatant Substances 0.000 description 11
- 238000012795 verification Methods 0.000 description 9
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 8
- 229960000723 ampicillin Drugs 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 239000000872 buffer Substances 0.000 description 7
- 108060005182 N-acylglucosamine 2-epimerase Proteins 0.000 description 6
- 102000002307 N-acylglucosamine 2-epimerase Human genes 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 238000001962 electrophoresis Methods 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 238000000855 fermentation Methods 0.000 description 5
- 230000004151 fermentation Effects 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 108010003007 mannose isomerase Proteins 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 229920002401 polyacrylamide Polymers 0.000 description 5
- 108090000769 Isomerases Proteins 0.000 description 4
- 102000004195 Isomerases Human genes 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 150000001413 amino acids Chemical group 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 230000035484 reaction time Effects 0.000 description 4
- 239000013049 sediment Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical group CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 241000282414 Homo sapiens Species 0.000 description 3
- 229920000057 Mannan Polymers 0.000 description 3
- 241001052560 Thallis Species 0.000 description 3
- 235000015872 dietary supplement Nutrition 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 238000001976 enzyme digestion Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 101710137647 Cellobiose 2-epimerase Proteins 0.000 description 2
- 229920002488 Hemicellulose Polymers 0.000 description 2
- 239000012880 LB liquid culture medium Substances 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 108010070944 alanylhistidine Proteins 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 238000012807 shake-flask culturing Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- HHGYNJRJIINWAK-FXQIFTODSA-N Ala-Ala-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N HHGYNJRJIINWAK-FXQIFTODSA-N 0.000 description 1
- WDIYWDJLXOCGRW-ACZMJKKPSA-N Ala-Asp-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O WDIYWDJLXOCGRW-ACZMJKKPSA-N 0.000 description 1
- KIUYPHAMDKDICO-WHFBIAKZSA-N Ala-Asp-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O KIUYPHAMDKDICO-WHFBIAKZSA-N 0.000 description 1
- LZRNYBIJOSKKRJ-XVYDVKMFSA-N Ala-Asp-His Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N LZRNYBIJOSKKRJ-XVYDVKMFSA-N 0.000 description 1
- NFDVJAKFMXHJEQ-HERUPUMHSA-N Ala-Asp-Trp Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N NFDVJAKFMXHJEQ-HERUPUMHSA-N 0.000 description 1
- KUDREHRZRIVKHS-UWJYBYFXSA-N Ala-Asp-Tyr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O KUDREHRZRIVKHS-UWJYBYFXSA-N 0.000 description 1
- WGDNWOMKBUXFHR-BQBZGAKWSA-N Ala-Gly-Arg Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N WGDNWOMKBUXFHR-BQBZGAKWSA-N 0.000 description 1
- KMGOBAQSCKTBGD-DLOVCJGASA-N Ala-His-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CC1=CN=CN1 KMGOBAQSCKTBGD-DLOVCJGASA-N 0.000 description 1
- FAJIYNONGXEXAI-CQDKDKBSSA-N Ala-His-Phe Chemical compound C([C@H](NC(=O)[C@@H](N)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CNC=N1 FAJIYNONGXEXAI-CQDKDKBSSA-N 0.000 description 1
- LBYMZCVBOKYZNS-CIUDSAMLSA-N Ala-Leu-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O LBYMZCVBOKYZNS-CIUDSAMLSA-N 0.000 description 1
- ZBLQIYPCUWZSRZ-QEJZJMRPSA-N Ala-Phe-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CC1=CC=CC=C1 ZBLQIYPCUWZSRZ-QEJZJMRPSA-N 0.000 description 1
- YXXPVUOMPSZURS-ZLIFDBKOSA-N Ala-Trp-Leu Chemical compound C1=CC=C2C(C[C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@H](C)N)=CNC2=C1 YXXPVUOMPSZURS-ZLIFDBKOSA-N 0.000 description 1
- VHAQSYHSDKERBS-XPUUQOCRSA-N Ala-Val-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O VHAQSYHSDKERBS-XPUUQOCRSA-N 0.000 description 1
- WVNFNPGXYADPPO-BQBZGAKWSA-N Arg-Gly-Ser Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O WVNFNPGXYADPPO-BQBZGAKWSA-N 0.000 description 1
- XFXZKCRBBOVJKS-BVSLBCMMSA-N Arg-Phe-Trp Chemical compound C([C@H](NC(=O)[C@H](CCCN=C(N)N)N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)C1=CC=CC=C1 XFXZKCRBBOVJKS-BVSLBCMMSA-N 0.000 description 1
- ASQKVGRCKOFKIU-KZVJFYERSA-N Arg-Thr-Ala Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)O ASQKVGRCKOFKIU-KZVJFYERSA-N 0.000 description 1
- CGXQUULXFWRJOI-SRVKXCTJSA-N Arg-Val-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(O)=O CGXQUULXFWRJOI-SRVKXCTJSA-N 0.000 description 1
- VOKWBBBXJONREA-DCAQKATOSA-N Asn-Met-His Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC(=O)N)N VOKWBBBXJONREA-DCAQKATOSA-N 0.000 description 1
- FMNBYVSGRCXWEK-FOHZUACHSA-N Asn-Thr-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O FMNBYVSGRCXWEK-FOHZUACHSA-N 0.000 description 1
- WSWYMRLTJVKRCE-ZLUOBGJFSA-N Asp-Ala-Asp Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(O)=O WSWYMRLTJVKRCE-ZLUOBGJFSA-N 0.000 description 1
- KVMPVNGOKHTUHZ-GCJQMDKQSA-N Asp-Ala-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KVMPVNGOKHTUHZ-GCJQMDKQSA-N 0.000 description 1
- OERMIMJQPQUIPK-FXQIFTODSA-N Asp-Arg-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O OERMIMJQPQUIPK-FXQIFTODSA-N 0.000 description 1
- VAWNQIGQPUOPQW-ACZMJKKPSA-N Asp-Glu-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O VAWNQIGQPUOPQW-ACZMJKKPSA-N 0.000 description 1
- SNDBKTFJWVEVPO-WHFBIAKZSA-N Asp-Gly-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(O)=O SNDBKTFJWVEVPO-WHFBIAKZSA-N 0.000 description 1
- MNQMTYSEKZHIDF-GCJQMDKQSA-N Asp-Thr-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O MNQMTYSEKZHIDF-GCJQMDKQSA-N 0.000 description 1
- YODBPLSWNJMZOJ-BPUTZDHNSA-N Asp-Trp-Arg Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CC(=O)O)N YODBPLSWNJMZOJ-BPUTZDHNSA-N 0.000 description 1
- BOXNGMVEVOGXOJ-UBHSHLNASA-N Asp-Trp-Ser Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC(=O)O)N BOXNGMVEVOGXOJ-UBHSHLNASA-N 0.000 description 1
- CLDCTNHPILWQCW-CIUDSAMLSA-N Cys-Arg-Glu Chemical compound C(C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CS)N)CN=C(N)N CLDCTNHPILWQCW-CIUDSAMLSA-N 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 108010067565 D-lyxose ketol-isomerase Proteins 0.000 description 1
- 150000000828 D-mannose derivatives Chemical class 0.000 description 1
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 1
- ZWQVYZXPYSYPJD-RYUDHWBXSA-N Glu-Gly-Phe Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 ZWQVYZXPYSYPJD-RYUDHWBXSA-N 0.000 description 1
- HILMIYALTUQTRC-XVKPBYJWSA-N Glu-Gly-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O HILMIYALTUQTRC-XVKPBYJWSA-N 0.000 description 1
- ZGKXAUIVGIBISK-SZMVWBNQSA-N Glu-His-Trp Chemical compound N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O ZGKXAUIVGIBISK-SZMVWBNQSA-N 0.000 description 1
- PJBVXVBTTFZPHJ-GUBZILKMSA-N Glu-Leu-Asp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)O)N PJBVXVBTTFZPHJ-GUBZILKMSA-N 0.000 description 1
- BRFJMRSRMOMIMU-WHFBIAKZSA-N Gly-Ala-Asn Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O BRFJMRSRMOMIMU-WHFBIAKZSA-N 0.000 description 1
- VSVZIEVNUYDAFR-YUMQZZPRSA-N Gly-Ala-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN VSVZIEVNUYDAFR-YUMQZZPRSA-N 0.000 description 1
- UQJNXZSSGQIPIQ-FBCQKBJTSA-N Gly-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)CN UQJNXZSSGQIPIQ-FBCQKBJTSA-N 0.000 description 1
- ALOBJFDJTMQQPW-ONGXEEELSA-N Gly-His-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)CN ALOBJFDJTMQQPW-ONGXEEELSA-N 0.000 description 1
- CQMFNTVQVLQRLT-JHEQGTHGSA-N Gly-Thr-Gln Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(O)=O CQMFNTVQVLQRLT-JHEQGTHGSA-N 0.000 description 1
- MYXNLWDWWOTERK-BHNWBGBOSA-N Gly-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN)O MYXNLWDWWOTERK-BHNWBGBOSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- BIAKMWKJMQLZOJ-ZKWXMUAHSA-N His-Ala-Ala Chemical compound C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(O)=O BIAKMWKJMQLZOJ-ZKWXMUAHSA-N 0.000 description 1
- TVQGUFGDVODUIF-LSJOCFKGSA-N His-Arg-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC1=CN=CN1)N TVQGUFGDVODUIF-LSJOCFKGSA-N 0.000 description 1
- STWGDDDFLUFCCA-GVXVVHGQSA-N His-Glu-Val Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O STWGDDDFLUFCCA-GVXVVHGQSA-N 0.000 description 1
- RAVLQPXCMRCLKT-KBPBESRZSA-N His-Gly-Phe Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O RAVLQPXCMRCLKT-KBPBESRZSA-N 0.000 description 1
- JSQIXEHORHLQEE-MEYUZBJRSA-N His-Phe-Thr Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O JSQIXEHORHLQEE-MEYUZBJRSA-N 0.000 description 1
- TYYLDKGBCJGJGW-UHFFFAOYSA-N L-tryptophan-L-tyrosine Natural products C=1NC2=CC=CC=C2C=1CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 TYYLDKGBCJGJGW-UHFFFAOYSA-N 0.000 description 1
- LZDNBBYBDGBADK-UHFFFAOYSA-N L-valyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)C(C)C)C(O)=O)=CNC2=C1 LZDNBBYBDGBADK-UHFFFAOYSA-N 0.000 description 1
- JQSXWJXBASFONF-KKUMJFAQSA-N Leu-Asp-Phe Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O JQSXWJXBASFONF-KKUMJFAQSA-N 0.000 description 1
- FEHQLKKBVJHSEC-SZMVWBNQSA-N Leu-Glu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(C)C)C(O)=O)=CNC2=C1 FEHQLKKBVJHSEC-SZMVWBNQSA-N 0.000 description 1
- VULJUQZPSOASBZ-SRVKXCTJSA-N Leu-Pro-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O VULJUQZPSOASBZ-SRVKXCTJSA-N 0.000 description 1
- AIMGJYMCTAABEN-GVXVVHGQSA-N Leu-Val-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O AIMGJYMCTAABEN-GVXVVHGQSA-N 0.000 description 1
- WGILOYIKJVQUPT-DCAQKATOSA-N Lys-Pro-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O WGILOYIKJVQUPT-DCAQKATOSA-N 0.000 description 1
- 208000012213 MPI-CDG Diseases 0.000 description 1
- IHITVQKJXQQGLJ-LPEHRKFASA-N Met-Asn-Pro Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N1CCC[C@@H]1C(=O)O)N IHITVQKJXQQGLJ-LPEHRKFASA-N 0.000 description 1
- 108010067749 Muconolactone Delta-isomerase Proteins 0.000 description 1
- 241000187480 Mycobacterium smegmatis Species 0.000 description 1
- WUGMRIBZSVSJNP-UHFFFAOYSA-N N-L-alanyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)C)C(O)=O)=CNC2=C1 WUGMRIBZSVSJNP-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 108010066427 N-valyltryptophan Proteins 0.000 description 1
- CLNJSLSHKJECME-BQBZGAKWSA-N Pro-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1 CLNJSLSHKJECME-BQBZGAKWSA-N 0.000 description 1
- LGMBKOAPPTYKLC-JYJNAYRXSA-N Pro-Phe-Arg Chemical compound C([C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(O)=O)NC(=O)[C@H]1NCCC1)C1=CC=CC=C1 LGMBKOAPPTYKLC-JYJNAYRXSA-N 0.000 description 1
- KDBHVPXBQADZKY-GUBZILKMSA-N Pro-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 KDBHVPXBQADZKY-GUBZILKMSA-N 0.000 description 1
- LNICFEXCAHIJOR-DCAQKATOSA-N Pro-Ser-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O LNICFEXCAHIJOR-DCAQKATOSA-N 0.000 description 1
- ZYJMLBCDFPIGNL-JYJNAYRXSA-N Pro-Tyr-Arg Chemical compound NC(=N)NCCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1)C(O)=O ZYJMLBCDFPIGNL-JYJNAYRXSA-N 0.000 description 1
- LZHHZYDPMZEMRX-STQMWFEESA-N Pro-Tyr-Gly Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(O)=O LZHHZYDPMZEMRX-STQMWFEESA-N 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- NUEHQDHDLDXCRU-GUBZILKMSA-N Ser-Pro-Arg Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O NUEHQDHDLDXCRU-GUBZILKMSA-N 0.000 description 1
- 241001647802 Thermobifida Species 0.000 description 1
- NRUPKQSXTJNQGD-XGEHTFHBSA-N Thr-Cys-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O NRUPKQSXTJNQGD-XGEHTFHBSA-N 0.000 description 1
- KERCOYANYUPLHJ-XGEHTFHBSA-N Thr-Pro-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O KERCOYANYUPLHJ-XGEHTFHBSA-N 0.000 description 1
- GJOBRAHDRIDAPT-NGTWOADLSA-N Thr-Trp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H]([C@@H](C)O)N GJOBRAHDRIDAPT-NGTWOADLSA-N 0.000 description 1
- PKUJMYZNJMRHEZ-XIRDDKMYSA-N Trp-Glu-Arg Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O PKUJMYZNJMRHEZ-XIRDDKMYSA-N 0.000 description 1
- FHVCMIMUGUFIOJ-IHPCNDPISA-N Trp-His-His Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC3=CN=CN3)C(=O)N[C@@H](CC4=CN=CN4)C(=O)O)N FHVCMIMUGUFIOJ-IHPCNDPISA-N 0.000 description 1
- OGZRZMJASKKMJZ-XIRDDKMYSA-N Trp-Leu-Asp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N OGZRZMJASKKMJZ-XIRDDKMYSA-N 0.000 description 1
- UJGDFQRPYGJBEH-AAEUAGOBSA-N Trp-Ser-Gly Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)O)N UJGDFQRPYGJBEH-AAEUAGOBSA-N 0.000 description 1
- HIZDHWHVOLUGOX-BPUTZDHNSA-N Trp-Ser-Val Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O HIZDHWHVOLUGOX-BPUTZDHNSA-N 0.000 description 1
- UPUNWAXSLPBMRK-XTWBLICNSA-N Trp-Thr-Thr Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O UPUNWAXSLPBMRK-XTWBLICNSA-N 0.000 description 1
- COLXBVRHSKPKIE-NYVOZVTQSA-N Trp-Trp-Asp Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(O)=O)C(O)=O COLXBVRHSKPKIE-NYVOZVTQSA-N 0.000 description 1
- QYSBJAUCUKHSLU-JYJNAYRXSA-N Tyr-Arg-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O QYSBJAUCUKHSLU-JYJNAYRXSA-N 0.000 description 1
- BRPKEERLGYNCNC-NHCYSSNCSA-N Val-Glu-Arg Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N BRPKEERLGYNCNC-NHCYSSNCSA-N 0.000 description 1
- RYQUMYBMOJYYDK-NHCYSSNCSA-N Val-Pro-Glu Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)O)N RYQUMYBMOJYYDK-NHCYSSNCSA-N 0.000 description 1
- TVGWMCTYUFBXAP-QTKMDUPCSA-N Val-Thr-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](C(C)C)N)O TVGWMCTYUFBXAP-QTKMDUPCSA-N 0.000 description 1
- HTONZBWRYUKUKC-RCWTZXSCSA-N Val-Thr-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O HTONZBWRYUKUKC-RCWTZXSCSA-N 0.000 description 1
- JPBGMZDTPVGGMQ-ULQDDVLXSA-N Val-Tyr-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N JPBGMZDTPVGGMQ-ULQDDVLXSA-N 0.000 description 1
- BGTDGENDNWGMDQ-KJEVXHAQSA-N Val-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](C(C)C)N)O BGTDGENDNWGMDQ-KJEVXHAQSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 108010047495 alanylglycine Proteins 0.000 description 1
- GZCGUPFRVQAUEE-KVTDHHQDSA-N aldehydo-D-mannose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O GZCGUPFRVQAUEE-KVTDHHQDSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 108010069926 arginyl-glycyl-serine Proteins 0.000 description 1
- 108010060035 arginylproline Proteins 0.000 description 1
- 108010093581 aspartyl-proline Proteins 0.000 description 1
- 108010047857 aspartylglycine Proteins 0.000 description 1
- 238000002869 basic local alignment search tool Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229940077731 carbohydrate nutrients Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 238000000105 evaporative light scattering detection Methods 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 108010049041 glutamylalanine Proteins 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 108010015792 glycyllysine Proteins 0.000 description 1
- 108010037850 glycylvaline Proteins 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 108010040030 histidinoalanine Proteins 0.000 description 1
- 108010036413 histidylglycine Proteins 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000001573 invertase Substances 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 108010093296 prolyl-prolyl-alanine Proteins 0.000 description 1
- 108010053725 prolylvaline Proteins 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 108010005652 splenotritin Proteins 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 108010061238 threonyl-glycine Proteins 0.000 description 1
- 108010044292 tryptophyltyrosine Proteins 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/02—Monosaccharides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y503/00—Intramolecular oxidoreductases (5.3)
- C12Y503/01—Intramolecular oxidoreductases (5.3) interconverting aldoses and ketoses (5.3.1)
- C12Y503/01007—Mannose isomerase (5.3.1.7)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
The invention discloses a D-mannose isomerase and application thereof, belonging to the technical field of bioengineering. The method adopts D-mannose isomerase coding THMI from thermophilic bacteria Thermobifida halotolerans, the THMI is recombined to an escherichia coli expression system to realize high-efficiency activity expression, the THMI enzyme of the recombinant expression realizes 36% mannose conversion under the conditions of a substrate D-fructose of 500g/L, a reaction temperature of 65 ℃ and a pH value of 9, meanwhile, the recombinant strain carries out whole-cell catalysis on fructose, and 31% mannose conversion is realized under the conditions of a substrate D-fructose of 500g/L, a reaction temperature of 60 ℃ and a pH value of 9. The invention lays a certain foundation for efficiently preparing mannose and is suitable for industrial production and application.
Description
Technical Field
The invention relates to a D-mannose isomerase and application thereof, belonging to the technical field of biological engineering.
Background
D-mannose is a natural bioactive monosaccharide, is a common food nutritional dietary supplement, can be particularly used as a nutritional dietary supplement affecting carbohydrate nutrients, and has a great contribution to human beings. D-mannose is a monomer unit in polysaccharide mannan, is an important component of many glycoproteins, and thus can be widely found in various foods in theory. The D-mannose has prebiotic effect, and can promote anti-inflammatory and anti-inflammatory cytokine expression, and as supplement, the D-mannose can reduce Salmonella typhimurium contamination, prevent urinary tract infection, and treat phosphomannose isomerase deficiency. D-mannose is widely used as a basic material for synthesizing vitamins, immunostimulating drugs and antitumor drugs. In general, D-mannose is a dietary supplement affecting the contribution of sugar nutrients to human health, and should be widely used in food products in view of its beneficial effects on human health.
In nature, D-mannose is usually present as a component of cellulose, hemicellulose, or mannan in various cell wall structures, which are produced by breakdown of hemicellulose by extracellular xylanases. At present, the D-mannose synthesis method mainly comprises an extraction separation method, a chemical synthesis method and an enzymatic preparation method, wherein the extraction separation method is used for extracting and separating mannose from plants, and the method has the disadvantages of complex process and low yield and purity; the chemical synthesis method is to obtain D-mannose by catalyzing isomerization of glucose, and the method usually needs complicated purification steps, easily causes solvent residue and then leads to generation of byproducts; the method for preparing D-mannose by the enzyme method takes D-fructose or D-glucose as a substrate and obtains the D-mannose by using biological enzyme catalysis, and the method has more and more important position in the preparation of the D-mannose, and has the advantages of mild reaction condition, less by-products, easy separation and purification, no environmental pollution, low cost and the like.
There are three major classes of D-mannose producing enzymes currently in use, which are divided into cellobiose-2-epimerase (EC 5.1.3.11), D-xylose isomerase (EC 5.3.1.15) and D-mannose isomerase (MIase, EC 5.3.1.7). The cellobiose-2-epimerase production can catalyze D-fructose or D-glucose as a substrate to produce D-mannose; and D-xylose isomerase and D-mannose isomerase catalyze the substrate D-fructose to generate D-mannose. A large number of three isomerases have been reported and characterized, however, most of them have a D-mannose conversion rate of less than 25%, a low substrate concentration and a long reaction time (several hours to 14 days). The highest invertase reported in the literature is derived from a mesophilic enzyme of the m. smegmatis strain, which achieves 35% conversion at low substrate concentration (6 uM). Therefore, these enzymes are limited by the conversion rate and the substrate concentration, and the scale-up production is difficult to realize. Therefore, the method for efficiently preparing the D-mannose under the high substrate concentration is obtained, and has good application value and commercial development significance.
Disclosure of Invention
In order to efficiently prepare D-mannose at a high substrate concentration, the invention provides a D-mannose isomerase, and the amino acid sequence of the D-mannose isomerase is shown as SEQ ID No. 1.
The invention also provides a recombinant escherichia coli for producing the D-mannan isomerase, wherein the recombinant escherichia coli takes escherichia coli as a host to express the D-mannose isomerase with an amino acid sequence shown as SEQ ID No. 1.
In one embodiment of the invention, the recombinant escherichia coli takes pET21a as an expression vector and E coli BL21(DE3) as a host.
The invention provides a method for preparing D-mannose, which takes D-mannose isomerase with an amino acid sequence shown as SEQ ID No.1 as a catalyst, takes D-fructose as a substrate, and adds the D-mannose isomerase with the amino acid sequence shown as SEQ ID No.1 into a reaction system containing the D-fructose for catalysis to obtain the D-mannose.
In one embodiment of the present invention, the nucleotide sequence of the D-mannose isomerase is shown as SEQ ID NO. 2.
In one embodiment of the present invention, the D-mannose isomerase is added in an amount of not less than 80U/mL.
In one embodiment of the present invention, the concentration of D-fructose in the reaction system is 1 to 700 g/L.
In one embodiment of the present invention, the concentration of D-fructose in the reaction system is 300-600 g/L.
In one embodiment of the present invention, in the reaction system, the reaction temperature is 20 to 80 ℃ and the pH is 2 to 11.
In one embodiment of the present invention, the reaction temperature in the reaction system is 65 ℃ and the pH is 9.
The invention also provides a method for producing D-mannose by whole-cell transformation, which takes the recombinant escherichia coli as a catalyst and the D-fructose as a substrate, and adds the recombinant escherichia coli into a reaction system containing the D-fructose for transformation to obtain the D-mannose.
In one embodiment of the present invention, the recombinant Escherichia coli is added to a solution of D-fructose with a concentration of 100-600g/L to an OD600 of 0.1-25, and then transformed at pH9.0 and a temperature of 60 ℃ for 1 hour to obtain a reaction solution.
In one embodiment of the present invention, the recombinant Escherichia coli is added to a D-fructose solution with a concentration of 300-600g/L until the OD600 is 10, and then the mixture is transformed at pH9.0 and a temperature of 60 ℃ for 1 hour to obtain a reaction solution.
The invention also provides the application of the D-mannose isomerase, the gene coding the D-mannose isomerase, the recombinant plasmid containing the gene coding the D-mannose isomerase, the host cell carrying the gene coding the D-mannose isomerase, or the method for preparing D-mannose in preparing D-mannose or products containing D-mannose.
Has the advantages that:
(1) the thermophilic D-mannose isomerase THMI expressed by the recombinant expression method realizes the high-efficiency active expression of the D-mannose isomerase by carrying out heterologous expression on the thermophilic D-mannose isomerase coding gene THMI derived from the thermophilic bacteria Thermobifida halolerans, is easy to ferment in a large scale and separate and purify products due to the strong protein secretion capacity of the escherichia coli, and realizes the high-efficiency conversion of 36% by using a high-concentration D-fructose substrate, which is the highest conversion rate reported at present. The method has simple operation process and high product purity, and is easy to realize industrial production of mannose.
(2) The invention utilizes the escherichia coli to produce mannose isomerase, and compared with other mannose isomerase, the mannose isomerase has great application advantages, high temperature resistance and high conversion rate. In addition, the host escherichia coli used in the process has stronger growth capacity, the extracellular secretion impurities are less, and the product is easy to separate and purify; secondly, high-concentration fructose is used as a reaction substrate, and mannose can be efficiently produced through catalysis.
Drawings
FIG. 1: protein expression was analyzed by SDS-PAGE.
FIG. 2: effect of different temperatures on the activity of D-mannose isomerase.
FIG. 3: effect of different pH values on the activity of D-mannose isomerase.
FIG. 4: effect of different substrate concentrations on the activity of D-mannose isomerase.
FIG. 5: the enzyme method is used for catalyzing the conversion rate of a high-concentration substrate D-fructose.
FIG. 6: effect of different final cell concentrations on the conversion of D-fructose catalyzed by whole cells.
FIG. 7: effect of different substrate concentrations on the conversion of D-fructose catalyzed by whole cells.
Detailed Description
The pET21a plasmid and E.coli BL21(DE3) referred to in the examples below were purchased from Stratagene, La Jolla, Calif., USA.
The media involved in the following examples are as follows:
LB liquid medium: 5g/L of yeast powder, 10g/L of peptone, 10g/L of sodium chloride and 100 mu g/mL of ampicillin concentration.
LB solid medium: 5g/L of yeast powder, 10g/L of peptone, 10g/L of sodium chloride, 100 mu g/mL of ampicillin concentration and 15g/L of agar.
D-mannose content determination:
d-mannose was quantitatively analyzed by high performance liquid chromatography HPLC. HPLC is Shimadzu LC20A system (Shimadzu, Japan) consisting of two LC-10A pumps, a SIL-10Avp autosampler, an evaporative light scattering detector and a Luna Amino 5-. mu.m 100A Amino column (250X 4.60mm) (Phenomenex). The mobile phase is acetonitrile/water (80: 20), the sample injection amount is 10ul, and the constant flow rate is 1.0 mL/min; column temperature: 30 ℃, detection wavelength: 250nm, D-mannose standard as quantitative standard sample.
D-mannose isomerase enzyme activity assay:
for precise determination of the enzyme activity, the reaction volume was 1mL, containing 50mM Tris-HCl buffer (pH 9.0), 500g/L D-fructose and appropriate amount of purified enzyme and addition of 1mM Na+And uniformly mixing the reaction system, and placing the mixture in a water bath at 65 ℃ for 30 minutes. One unit of enzyme activity is defined as the amount of enzyme required to produce 1. mu. mol D-mannose per minute at 60 ℃ and pH 9.0. Enzyme specific activity is defined as the number of units of enzyme contained per mg of pure enzyme protein.
Example 1: acquisition of D-mannose isomerase and construction of recombinant escherichia coli
1. Obtaining N-acyl-D-glucopyranosamine 2-epimerase (N-acetyl-D-glucosamine 2-epimerase) with a nucleotide sequence shown as SEQ ID NO.2 from an NCBI genome database; N-acyl-D-glucopyranosamine 2-epimerase (N-acetyl-D-glucosamine 2-epimerase) is analyzed by NCBI/Basic Local Alignment Search Tool, the homology of the enzyme and D-mannose isomerase is less than 50%, and the enzyme coded by the sequence has a far-away evolutionary relationship with a D-mannose isomerase family.
2. Artificially synthesizing a target gene (the nucleotide sequence is shown as SEQ ID NO. 2), designing a recombinant primer, and connecting the target gene and pET21a plasmid after restriction enzyme digestion by restriction enzymes NdeI and XhoI to obtain a connection product; transforming E.coli JM109 with the ligation product to obtain a transformation product, coating the transformation product on an ampicillin-containing LB solid medium, performing inverted culture in a 37 ℃ constant temperature incubator for 8-12 h to obtain a transformant, selecting the transformant, inoculating the transformant to an ampicillin-containing LB liquid medium, performing shake flask culture at 37 ℃ and 120-180 rpm for 8-12 h, extracting plasmids, performing enzyme digestion verification and sequencing verification, and obtaining the recombinant plasmid pET21 a-target gene after verification is correct.
And (3) primer F: 5'-CGGCATATGAACCCGTGGACCACCCGGACCGCGCAC-3' (SEQ ID NO.3) primer R: 5'-CCGCTCGAGGCCGTCTGCGGCCAGTGCCCCGGCCAG-3' (SEQ ID NO.4)
Transforming a recombinant plasmid pET21 a-target gene to Escherichia coli E.coli BL21(DE3), carrying out inverted culture in a constant temperature incubator at 37 ℃ for 8-12 h on an LB solid culture medium containing ampicillin to obtain a transformant, selecting the transformant, inoculating the transformant to an LB liquid culture medium containing ampicillin, carrying out shake-flask culture at 37 ℃ and 120-180 rpm for 8-12 h, extracting a plasmid, and carrying out enzyme digestion verification and sequencing verification to verify the correctness, namely the recombinant Escherichia coli E.coli BL21(DE3)/pET21 a-target gene.
Example 2: shake flask fermentation for producing enzyme
The method comprises the following specific steps:
(1) inoculating a single colony of the recombinant Escherichia coli E.coli BL21(DE3)/pET21 a-target gene obtained in example 1 into a test tube of 5mL LB liquid culture medium containing 100ug/mL ampicillin, and placing the test tube at 37 ℃ and under the condition of 200rpm for shaking culture for 12-14h to obtain a seed solution;
(2) transferring 0.5mL of the seed solution obtained in the step (1) into a shake flask containing 50mL of fresh LB liquid medium (containing 100ug/mL of ampicillin), and placing the shake flask at 37 ℃ and under the condition of 200rpm for shake culture; culturing until OD600 value is 0.4-0.5, adding IPTG with final concentration of 0.1mM into the shake flask, placing the shake flask at 15 deg.C and 200rpm for low temperature induction expression of protein, and culturing for 24h to obtain fermentation liquor;
(3) centrifuging the fermentation liquor obtained in the step (2) for 30min at 5000rpm, filtering to obtain thalli, adding 12.5mL of 50mM PBS (pH 7.0) into each 100mL of thalli obtained from the bacterial liquid, and resuspending the thalli to obtain a mixed liquor;
(4) carrying out ultrasonic treatment on the mixed solution obtained in the step (3) for 7.5min, crushing bacterial cells by adopting ultrasonic waves to obtain a cell crushing solution, carrying out SDS-polyacrylamide gel protein electrophoresis verification on the obtained cell crushing solution, and analyzing the expression quantity and purity of the target protein, wherein the result is shown in figure 1;
(5) centrifuging the cell disruption solution (10000rpm, 4 ℃) for 10min, filtering, separating to obtain cell disruption solution sediment and cell disruption solution supernatant, respectively performing SDS-polyacrylamide gel protein electrophoresis verification on the cell disruption solution sediment and the cell disruption solution supernatant, and analyzing the expression quantity and the purity of the target protein, wherein the result is shown in figure 1;
using the method of example 1-2, except that pET21a was not linked to the target gene, a cell disruption solution of pET21a/BL21(DE3) was prepared; performing SDS-polyacrylamide gel protein electrophoresis verification on the obtained cell disruption solution, and analyzing the expression amount and purity of the target protein, wherein the result is shown in figure 1;
as shown in fig. 1: taking a cell disruption solution of pET21a/BL21(DE3) under the same culture conditions as a control, wherein a protein band is obviously added at a position of about 45.5kDa in a whole cell disruption solution and a supernatant of a fine cell disruption solution of E.coli BL21(DE3)/pET21 a-target genes, and no obvious band is found at the position by cell disruption solution precipitation;
further carrying out D-fructose catalytic reaction on supernatant of cell disruption solution of E.coli BL21(DE3)/pET21 a-target gene, wherein the reaction system is 1mL, the reaction system contains 100g/L of D-fructose, 100 mu L of supernatant of cell disruption solution has pH of 9.0, uniformly mixing, carrying out reaction for 1h at 60 ℃, inactivating enzyme by boiling water bath after the reaction is finished, and appropriately diluting for next step HPLC determination;
the results, as detected by HPLC, show: coli BL21(DE3)/pET21 a-target gene cell disruption liquid supernatant and D-mannose standard substance have absorption peaks at the wavelength of 250 nm; and preliminarily judging that the target protein is D-mannose isomerase by combining the electrophoresis verification result of the SDS-polyacrylamide gel protein.
(6) D-mannose isomerase biopsy is carried out on the E.coli BL21(DE3)/pET21 a-target gene cell disruption solution sediment obtained in the step (5) and the cell disruption solution supernatant, and the result shows that no enzyme activity is detected in the cell disruption solution sediment; the activity of the D-mannose isomerase in the supernatant of the cell disruption solution is 812U/mL.
From the results, it was found that the mannose-converting enzyme activity of the supernatant of the E.coli BL21(DE3)/pET21 a-target gene cell disruption solution was 812U/mL, and it was found that N-acyl-D-glucosamine2-epimerase (N-acetyl-D-glucosamine 2-epimerase) and D-mannose isomerase had very low homology, but they did have the enzyme activity of D-mannose isomerase, and thus N-acyl-D-glucosamine2-epimerase (N-acetyl-D-glucosamine 2-epimerase) was used as D-mannose isomerase.
Example 3: purification of D-mannose isomerase
The method comprises the following specific steps:
(1) the supernatant of the cell disruption solution of E.coli BL21(DE3)/pET21 a-objective gene obtained in step (5) of example 2 was filtered through a 0.45 μm cellulose acetate membrane to obtain a filtrate.
(2) The column was mounted, washed repeatedly several times with distilled water, 50mL of PBS buffer solution of pH 7.0 was added to the column, and allowed to stand for 4 hours. Adding the filtrate obtained in the step (1) into a column, fully and uniformly mixing, stirring by using a glass rod at the temperature of 4 ℃, uniformly mixing the filtrate with Ni-NTA agarose gel, stirring once for 20min, stirring for 8 times, and finishing after 4 h; the supernatant was eluted at a slower flow rate, 50mL of imidazole PBS buffer pH 7.0 at 0mM, 10mM, 20mM, 30mM, 50mM, respectively, was added to remove impure proteins, leaving a single protein, and finally 500mM of imidazole PBS buffer pH 7.0 was added to elute the target protein.
(3) Immediately dialyzing the target protein obtained in the step (2), wherein the dialysis buffer solution is PBS (pH 7.0), replacing the dialysate once for 3h and replacing for 3-4 times, and the whole purification and dialysis processes are carried out at 4 ℃ to obtain the purified D-mannose isomerase.
SDS-PAGE protein electrophoresis detection is carried out on the purified D-mannose isomerase, the result is shown in figure 1, the D-mannose isomerase SDS-polyacrylamide gel protein electrophoresis result shows that the size is 45.5kDa and is consistent with the theoretical molecular size, and the high-efficiency activity expression of the D-mannose isomerase protein is proved, and the protein purification band is single.
Example 4: determination of influencing factors in D-mannose isomerase-catalyzed reaction
The enzymatic determination and analysis of D-mannose isomerase by using D-fructose as a substrate comprises the following specific steps:
(1) effect of temperature on D-mannose isomerase catalyzed reactions
The reaction system is 1mL, wherein the substrate concentration is 500g/L, the purified D-mannose isomerase obtained in example 3 is 0.1mL, the reaction pH is 7.0, the reaction systems are respectively reacted at 20 ℃, 30 ℃, 40 ℃, 45 ℃, 50 ℃, 55 ℃, 60 ℃, 65 ℃, 70 ℃, 75 ℃ and 80 ℃, the reaction time is 1h, the enzyme activity at each reaction temperature is respectively measured after the reaction is finished, and the result is shown in figure 2, and the optimal reaction temperature of the enzyme is 65 ℃.
(2) Effect of pH on D-mannose isomerase catalyzed reactions
The reaction system is 1mL, wherein the substrate concentration is 500g/L, the pure enzyme is 0.1mL, the reaction temperature is 65 ℃, the reaction system is respectively reacted under the conditions of pH 2.0, pH 3.0, pH 4.0, pH 5.0, pH 6.0, pH 7.0, pH 8.0, pH9.0, pH 10.0 and pH 11.0, the reaction time is 1h, the enzyme activity under each pH condition is respectively measured after the reaction is finished, and the result is shown in figure 3, and the result shows that the optimum reaction pH of the enzyme is 9.0.
(3) Effect of substrate concentration on D-mannose isomerase catalyzed reactions
The reaction system is 1mL, wherein the pure enzyme is 0.1mL, the reaction temperature is 65 ℃, the reaction pH value is 9.0, the reaction is carried out under the conditions that the concentrations of D-fructose substrates are 0.1g/L, 1g/L, 5g/L, 25g/L, 50g/L, 100g/L, 200g/L, 300g/L, 400g/L, 500g/L, 600g/L and 700g/L respectively, the reaction time is 1h, the enzyme activity under the conditions of the substrate concentrations is respectively measured after the reaction is finished, and the result is shown in FIG. 4, and the result shows that the optimal substrate concentration of the enzyme reacts with 500 g/L.
EXAMPLE 5 enzymatic catalysis of D-fructose to D-mannose
The method comprises the following specific steps:
adding the purified D-mannose isomerase obtained in example 3 into D-fructose solutions with concentrations of 300g/L, 400g/L, 500g/L and 600g/L respectively according to the addition amount of 80U/mL, and reacting for 1h at the temperature of 65 ℃ and the pH of 9.0 to obtain a reaction solution;
detecting the content of D-mannose in the reaction solution, and calculating the mannose conversion rate; the calculation method of the mannose conversion rate comprises the following steps: the conversion (%) (content of produced D-mannose/content of total D-fructose) was 100%, and the results are shown in fig. 5.
As can be seen from FIG. 5, the conversion rates of mannose obtained under the conditions of substrate concentrations of 300g/L, 400g/L, 500g/L and 600g/L were 30%, 32%, 36% and 31%, respectively. This indicates that the THMI enzyme has very high conversion rate, which is obviously higher than the maximum 25% conversion rate of other mannose isomerase currently reported (Zhang et al, 2019, Process Biochemistry 83: 131-.
Example 6: whole-cell catalysis D-fructose preparation D-mannose
The method comprises the following specific steps:
the fermentation broth obtained in step (2) of example 2 was centrifuged to collect bacterial cells, the collected bacterial cells were washed twice with 50mM PBS buffer, and then resuspended in pre-cooled 50mM PBS buffer (pH 7.0) at a cell density of OD600 ═ 100, to obtain a resuspended cell broth;
the resuspended cell fluid was added to a D-fructose solution with a concentration of 500g/L until OD600 was 0.1, 1, 5, 10, 25, respectively, and then the mixture was transformed at pH9.0 and a temperature of 60 ℃ for 1 hour to obtain a reaction solution.
The content of D-mannose in the reaction solution was measured and the conversion of D-mannose was calculated, and as a result, as shown in FIG. 6, the conversion was 4.9%, 13.3%, 21.2%, 31.5%, and 29.8% for OD600 final concentrations of 0.1, 1, 5, 10, and 25, respectively, and the result showed that the optimal reaction condition was achieved for OD600 final concentration of 10.
Example 7: whole-cell catalysis D-fructose preparation D-mannose
The method comprises the following specific steps:
the fermentation broth obtained in step (2) of example 2 was centrifuged to collect bacterial cells, the collected bacterial cells were washed twice with 50mM PBS buffer, and then resuspended in pre-cooled 50mM PBS buffer (pH 7.0) at a cell density of OD600 ═ 100, to obtain a resuspended cell broth;
the resuspended cell fluid was added to D-fructose solutions at concentrations of 100g/L, 200g/L, 300g/L, 400g/L, 500g/L and 600g/L, respectively, to an OD600 of 10, and then the mixture was transformed at pH9.0 and a temperature of 60 ℃ for 1 hour to obtain a reaction solution.
As a result of measuring the content of D-mannose in the reaction solution and calculating the conversion rate of D-mannose, as shown in FIG. 7, the conversion rates of mannose obtained under the conditions of substrate concentrations of 100g/L, 200g/L, 300g/L, 400g/L, 500g/L and 600g/L were 28%, 27.8%, 30.1%, 30%, 31.5% and 31.3%, respectively, and the result showed that the conversion rate of mannose obtained under the condition of substrate concentration of 500g/L was the best.
Although the present invention has been described with reference to the preferred embodiments, it should be understood that various changes and modifications can be made therein by those skilled in the art without departing from the spirit and scope of the invention as defined in the appended claims.
SEQUENCE LISTING
<110> Zhejiang agriculture and forestry university
<120> D-mannose isomerase and application thereof
<130> BAA200669A
<160> 4
<170> PatentIn version 3.3
<210> 1
<211> 407
<212> PRT
<213> Artificial sequence
<400> 1
Met Asn Pro Trp Thr Thr Arg Thr Ala His Arg Ala Trp Leu Asp Ala
1 5 10 15
Glu Ala Arg Arg Leu Leu Gly Phe Val Ser Ala Ala Thr His Pro Glu
20 25 30
His Gly Phe Ala Trp Leu Asp Ala Asp Gly Thr Pro Val Pro Glu Gln
35 40 45
Gly Thr Gln Thr Trp Ile Thr Cys Arg Val Thr His Val Ala Ala Leu
50 55 60
Ala His Leu Glu Gly Val Pro Gly Ala Gly Ala Leu Ala Asp His Gly
65 70 75 80
Val Arg Ala Leu Ser Gly Pro Ala Arg Asp Arg Asp His Asp Gly Trp
85 90 95
Phe Ala Ala Leu Asp Ala Asp Gly Thr Pro Ser Ser Pro Arg Lys Glu
100 105 110
Ala Tyr Gln His Ala Phe Val Leu Leu Ala Ala Ser Ser Ala Ala Leu
115 120 125
Ala Gly Arg Pro Gly Ala Arg Glu Leu Leu Asp Ala Ala Val Asp Val
130 135 140
Val Glu Arg Arg Phe Trp Asp Glu Ala Ala Gly Arg Cys Arg Glu Ser
145 150 155 160
Trp Glu Arg Asp Trp Ser Ala Asp Glu Pro Tyr Arg Gly Ala Asn Ser
165 170 175
Asn Met His Leu Val Glu Ala Phe Leu Ala Val Gly Asp Ala Thr Gly
180 185 190
Glu Arg Val Trp Ala Asp Arg Ala Leu Arg Met Ala Arg Phe Phe Val
195 200 205
His Glu Val Ala Ala Ala Arg Asp Trp Arg Leu Pro Glu His Phe Thr
210 215 220
Ala Asp Trp Arg Val Val Ala Asp Tyr Asn Thr Gly Asp Arg Ala His
225 230 235 240
Pro Phe Arg Pro Tyr Gly Val Thr Val Gly His Val Leu Glu Trp Ala
245 250 255
Arg Leu Leu Val His Leu Glu Ala Ala Leu Pro Asp Ala Pro Gly Trp
260 265 270
Leu Leu Ala Asp Ala Glu Ala Met Phe Ala Ala Ala Val Glu Arg Gly
275 280 285
Trp Ser Val Asp Gly Ser Glu Gly Phe Val Tyr Thr Leu Asp Phe Asp
290 295 300
Asp Ala Pro Val Val Arg Ala Arg Met His Trp Val Ala Ala Glu Ala
305 310 315 320
Val Ser Ala Ala Ala Val Leu Gly Arg Arg Thr Gly Asp Glu Arg Tyr
325 330 335
Glu His Trp Tyr Arg Val Trp Trp Asp His Ala Ala Ala His Phe Val
340 345 350
Asp Thr Ala Arg Gly Ser Trp His His Glu Leu Asp Pro Ser Leu Arg
355 360 365
Pro Pro Ala Gly Gly Thr Trp Ser Gly Lys Pro Asp Val Tyr His Ala
370 375 380
Tyr Gln Ala Thr Arg Leu Pro Leu Leu Pro Leu Ala Pro Ser Leu Ala
385 390 395 400
Gly Ala Leu Ala Ala Asp Gly
405
<210> 2
<211> 1224
<212> DNA
<213> Artificial sequence
<400> 2
atgaacccgt ggaccacccg gaccgcgcac cgggcctggc tggacgccga ggcccggcgc 60
ctgctgggct tcgtctccgc cgccacccac cccgagcacg gcttcgcctg gctggacgcc 120
gacggcacgc cggtgcccga gcagggcacg cagacctgga tcacctgccg cgtcacccac 180
gtggccgcgc tggcgcacct ggagggcgtc cccggcgcgg gagcgctcgc cgaccacggg 240
gtgcgggcgc tgtcgggccc cgcgcgcgac cgcgaccacg acggctggtt cgccgcactg 300
gacgccgacg gcacgccctc ctcaccgcgc aaggaggcct accagcacgc gttcgtgctg 360
ctggccgcct ccagcgcggc gctcgccgga cgcccggggg cgcgggaact gctcgacgcg 420
gcggtcgacg tcgtcgaacg gcgcttctgg gacgaggcgg cgggccgctg ccgggagagc 480
tgggagcggg actggagcgc cgacgagccc taccggggcg ccaacagcaa catgcacctg 540
gtggaggcgt tcctcgccgt cggcgacgcc accggtgagc gggtgtgggc cgaccgggcg 600
ctgcgcatgg cccgcttctt cgtccacgag gtggccgccg cacgcgactg gcggctgccc 660
gagcacttca ccgccgactg gcgggtggtg gccgactaca acaccggcga ccgcgcccac 720
ccgttccgcc cctacggggt gacggtgggc cacgtcctgg agtgggcccg cctgctggtg 780
cacctggagg cggcgctgcc ggacgccccg gggtggctgc tggccgacgc cgaggcgatg 840
ttcgccgccg cggtggagcg cggctggtcg gtggacggct ccgagggctt cgtctacacc 900
ctggacttcg acgacgcccc cgtggtgcgc gcccgcatgc actgggtggc ggccgaggcg 960
gtctccgcgg cggccgtgct gggccggcgc accggcgacg aacgctacga gcactggtac 1020
cgggtgtggt gggaccacgc cgccgcgcac ttcgtggaca ccgcgcgcgg cagttggcac 1080
cacgaactgg acccgtcgct gcggcccccg gcgggcggca cctggagcgg caaaccggac 1140
gtgtaccacg cctaccaggc gacccgcctg ccgctgctgc cgctcgcccc cagcctggcc 1200
ggggcactgg ccgcagacgg ctga 1224
<210> 3
<211> 36
<212> DNA
<213> Artificial sequence
<400> 3
cggcatatga acccgtggac cacccggacc gcgcac 36
<210> 4
<211> 36
<212> DNA
<213> Artificial sequence
<400> 4
ccgctcgagg ccgtctgcgg ccagtgcccc ggccag 36
Claims (8)
1. A method for preparing D-mannose is characterized in that D-mannose isomerase with an amino acid sequence shown as SEQ ID NO.1 is used as a catalyst, D-fructose is used as a substrate, and the D-mannose isomerase is added into a reaction system containing the D-fructose for catalysis to obtain the D-mannose.
2. The method for preparing D-mannose according to claim 1, wherein the amount of the D-mannose isomerase added is not less than 80U/mL.
3. The process for producing D-mannose according to claim 2, wherein the concentration of D-fructose in the reaction system is 1 to 700 g/L.
4. The method for preparing D-mannose according to claim 3, wherein the reaction temperature is 20 to 80 ℃ and the pH is 2 to 11 in the reaction system.
5. A method for producing D-mannose by whole cell transformation is characterized in that recombinant Escherichia coli is used as a catalyst, D-fructose is used as a substrate, and the recombinant Escherichia coli is added into a reaction system containing the D-fructose for transformation to obtain the D-mannose; the recombinant Escherichia coli takes Escherichia coli as a host to express D-mannose isomerase with an amino acid sequence shown as SEQ ID No. 1.
6. The method as claimed in claim 5, wherein the recombinant Escherichia coli is added to a solution of D-fructose having a concentration of 100-600g/L to an OD600 of 0.1-25, and then transformed at pH9.0 and a temperature of 60 ℃ for 1 hour to obtain a reaction solution.
7. The method as claimed in claim 5 or 6, wherein the recombinant Escherichia coli is added to a solution of D-fructose having a concentration of 300-600g/L to an OD600 of 10, and then transformed at pH9.0 and a temperature of 60 ℃ for 1 hour to obtain a reaction solution.
8. The use of a recombinant plasmid encoding a D-mannose isomerase with a nucleotide sequence as shown in SEQ ID No.2, or a recombinant plasmid comprising a D-mannose isomerase with an amino acid sequence as shown in SEQ ID No.1, or a host cell carrying a D-mannose isomerase with an amino acid sequence as shown in SEQ ID No.1, or a method according to any one of claims 1 to 7 for the preparation of D-mannose or a product containing D-mannose.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010811740.9A CN111944796B (en) | 2020-08-13 | 2020-08-13 | D-mannose isomerase and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010811740.9A CN111944796B (en) | 2020-08-13 | 2020-08-13 | D-mannose isomerase and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111944796A CN111944796A (en) | 2020-11-17 |
CN111944796B true CN111944796B (en) | 2021-11-16 |
Family
ID=73333087
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010811740.9A Active CN111944796B (en) | 2020-08-13 | 2020-08-13 | D-mannose isomerase and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111944796B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113403297A (en) * | 2021-08-03 | 2021-09-17 | 北京诚志高科生物科技有限公司 | D-mannose isomerase immobilized enzyme and preparation method and application thereof |
CN115725558A (en) * | 2022-09-01 | 2023-03-03 | 沈阳农业大学 | High-stability ethanol-resistant mannose isomerase and coding gene thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103088090B (en) * | 2013-03-01 | 2014-06-04 | 南京工业大学 | Application of N-acetylglucosamine isomerase in production of N-acetylmannosamine |
CN108611356B (en) * | 2016-12-10 | 2021-07-06 | 中国科学院大连化学物理研究所 | Endo-beta-1, 4-mannase coding gene and preparation and application thereof |
CN109929861B (en) * | 2017-12-15 | 2022-11-22 | 中国科学院大连化学物理研究所 | Encoding gene of glucomannanase, enzyme, preparation and application thereof |
CN109161514B (en) * | 2018-09-28 | 2020-08-04 | 江南大学 | Recombinant D-mannose isomerase and application thereof in D-mannose production |
-
2020
- 2020-08-13 CN CN202010811740.9A patent/CN111944796B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN111944796A (en) | 2020-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106191170B (en) | A kind of method that enzyme process prepares atriphos | |
CN111944796B (en) | D-mannose isomerase and application thereof | |
CN109486782B (en) | Method for improving sucrose phosphorylase expression efficiency through molecular chaperone co-expression | |
CN108690854B (en) | Method for producing L-glufosinate-ammonium by using chemical-enzymatic method | |
CN111172127A (en) | Application of sucrose phosphorylase in preparation of glycerol glucoside | |
CN111690624A (en) | Method for synthesizing 2-O-alpha-D-glycerol glucoside by using microorganisms | |
CN110656077B (en) | Method for producing sucrose phosphorylase and application thereof | |
CN109652395A (en) | One Bacillus species chitinase and its application | |
CN113736763B (en) | Myrosinase Rmmr and application thereof in preparation of sulforaphane and sulforaphane | |
CN112695025B (en) | Mutant of cellobiose epimerase and application thereof | |
CN105349516A (en) | Threonine deaminase, coding gene, carrier, engineering bacterium and applications | |
CN103627691B (en) | A kind of immobilization glutathione synthetase and its preparation and application | |
CN109897812B (en) | Recombinant bacterium for expressing chondroitin 4-sulfate transferase gene and application thereof | |
KR20180041377A (en) | A Novel alpha-neoagarobiose hydrolase from Gayadomonas joobiniege G7 and use thereof | |
CN116376859A (en) | Dihydrofolate reductase and application thereof | |
CN110804602B (en) | L-aspartic acid beta-decarboxylase mutant and application thereof | |
CN114836406A (en) | Agarase mutant with improved catalytic activity and application thereof | |
CN109402090B (en) | Beta-1,3 endoglucanase with immune enhancing activity and derived from scapharca broughtonii and encoding polynucleotide thereof | |
CN115011622A (en) | Screening method and application of D-psicose 3-epimerase mutant | |
KR101228975B1 (en) | N-acyl-D-glucosamine 2-epimerase and Method for production of mannose from glucose using the same | |
CN110656054A (en) | Recombinant trichoderma reesei for extracellularly secreting alginate lyase and application thereof | |
EP2186904B1 (en) | Method for producing glucose derivatives | |
CN111534498A (en) | Cyclodextrin glucosyltransferase mutant with improved disproportionation specific activity and AA-2G yield | |
CN114231509B (en) | Sucrose phosphorylase and glucosyl glycerol production process | |
CN114908076B (en) | Algin lyase for directionally obtaining fucoidan trisaccharide product and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |